13D Filing: Brady John Robert and Stony Hill Corp (STNY)

Page 1 of 9

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
John Brady 0 2,000,000 0 2,000,000 2,000,000 13.1%
John R. Brady Living Trust 1,600,000 2,000,000 1,600,000 2,000,000 1,600,000 10.4%
Equinox Consulting 400,000 2,000,000 400,000 2,000,000 400,000 2.6%

Page 1 of 9 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Stony Hill Corp.

(Name of Issuer)

Common Stock, $0.00001 Par Value

(Title of Class of Securities)

862079100

(CUSIP Number)

John Brady

c/o Stony Hill Corp.

9701 Wilshire Blvd., Suite 1000

Beverly Hills, California 90212

Tel: (310) 356-7374
(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

November 4, 2016

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o .

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Follow Applied Biosciences Corp.

Page 1 of 9